Company / Operating Income
Integra Lifesciences Holdings Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$493.4M
FY2025
5-year range
-$493.4M / $238.9M
FY2021-FY2025
Trend
-1836.5%
vs FY2024
Sector context
#151 of 156
Health Care
What the data says
Operating Income changed -1837% YoY in FY2025, a notable deviation from the 9-year average annual change of -201%.
Based on SEC 10-K filings.
-$493M in FY2025.
Declined from $112M to -$493M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 156This company -$493.4M Sector average $733.1M
▼
-167.3% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 1836.5% year-over-year.
- Ranks #151 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$493.4M | -1836.5% |
| FY2024 | $28.4M | -74.5% |
| FY2023 | $111.5M | -53.3% |
| FY2022 | $238.9M | +21.1% |
| FY2021 | $197.2M | +30.3% |
| FY2020 | $151.4M | +61.4% |
| FY2019 | $93.8M | -15.5% |
| FY2018 | $111.0M | +39.5% |
| FY2017 | $79.6M | +17.3% |
| FY2016 | $67.9M | -14.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026